PKCδ is activated in the liver of obese Zucker rats and mediates diet-induced whole body insulin resistance and hepatocyte cellular insulin resistance

Journal of Nutritional Biochemistry

Volumn 25, Issue 3, 2014, Pages 281-288

  Greene, Michael W ^a,b   Burrington, Christine M ^b   Luo, Yuwen ^a   Ruhoff, Mary S ^b   Lynch, Darin T ^b   Chaithongdi, Niyutchai ^c  

^a AUBURN UNIVERSITY   (United States)

^b BASSETT RESEARCH INSTITUTE   (United States)

^c BASSETT MEDICAL CENTER   (United States)

Author keywords

Hepatocyte; Insulin; Protein kinase C

Indexed keywords

HEPATOCYTE; INSULIN; PROTEIN KINASE C;

ANIMALS; ENZYME ACTIVATION; INSULIN RESISTANCE; LIVER; MALE; OBESITY; PROTEIN KINASE C-DELTA; RATS; RATS, SPRAGUE-DAWLEY; RATS, ZUCKER;

EID: 84893539480     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2013.10.008     Document Type: Article

References (50)

1. Meigs J.B., Wilson P.W., Fox C.S., Vasan R.S., Nathan D.M., Sullivan L., et al. Body mass index, metabolic syndrome and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006, 10.1210/jc.2006-0594.
2. Semenkovich C.F. Insulin resistance and atherosclerosis. J Clin Invest 2006, 116:1813-1822.
3. Goldfine A.B., Bouche C., Parker R.A., Kim C., Kerivan A., Soeldner J.S., et al. Insulin resistance is a poor predictor of type 2 diabetes in individuals with no family history of disease. Proc Natl Acad Sci U S A 2003, 100:2724-2729.
4. Jou J., Choi S.S., Diehl A.M. Mechanisms of disease progression in nonalcoholic fatty liver disease. Semin Liver Dis 2008, 28:370-379.
5. Kumashiro N., Erion D.M., Zhang D., Kahn M., Beddow S.A., Chu X., et al. Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease. Proc Natl Acad Sci U S A 2011, 108:16381-16385.
6. Bezy O., Tran T.T., Pihlajamaki J., Suzuki R., Emanuelli B., Winnay J., et al. PKCdelta regulates hepatic insulin sensitivity and hepatosteatosis in mice and humans. J Clin Invest 2011, 121:2504-2517.
7. Considine R.V., Nyce M.R., Allen L.E., Morales L.M., Triester S., Serrano J., et al. Protein kinase C is increased in the liver of humans and rats with non-insulin-dependent diabetes mellitus: an alteration not due to hyperglycemia. J Clin Invest 1995, 95:2938-2944.
8. Itani S.I., Ruderman N.B., Schmieder F., Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 2002, 51:2005-2011.
9. Samuel V.T., Liu Z.X., Geisler J.G., Bhanot S., Monia B., Shulman G.I. Antisense oligonucleotide reduction of hepatic PKCe expression prevents fat induced hepatic insulin resistance. Diabetes 2006, 55:A4-A5.
10. Schmitz-Peiffer C., Laybutt D.R., Burchfield J.G., Gurisik E., Narasimhan S., Mitchell C.J., et al. Inhibition of PKCepsilon improves glucose-stimulated insulin secretion and reduces insulin clearance. Cell Metab 2007, 6:320-328.
11. Samuel V.T., Liu Z.X., Wang A., Beddow S.A., Geisler J.G., Kahn M., et al. Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease. J Clin Invest 2007, 117:739-745.
12. Frangioudakis G., Burchfield J.G., Narasimhan S., Cooney G.J., Leitges M., Biden T.J., et al. Diverse roles for protein kinase C delta and protein kinase C epsilon in the generation of high-fat-diet-induced glucose intolerance in mice: regulation of lipogenesis by protein kinase C delta. Diabetologia 2009, 52:2616-2620.
13. Boden G., She P., Mozzoli M., Cheung P., Gumireddy K., Reddy P., et al. Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-{kappa}B pathway in rat liver. Diabetes 2005, 54:3458-3465.
14. Lam T.K., Yoshii H., Haber C.A., Bogdanovic E., Lam L., Fantus I.G., et al. Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-delta. Am J Physiol Endocrinol Metab 2002, 283:E682-E691.
15. Talior I., Tennenbaum T., Kuroki T., Eldar-Finkelman H. PKC-delta-dependent activation of oxidative stress in adipocytes of obese and insulin-resistant mice: role for NADPH oxidase. Am J Physiol Endocrinol Metab 2005, 288:E405-E411.
16. Talior I., Yarkoni M., Bashan N., Eldar-Finkelman H. Increased glucose uptake promotes oxidative stress and PKC-delta activation in adipocytes of obese, insulin-resistant mice. Am J Physiol Endocrinol Metab 2003, 285:E295-E302.
17. Uchida T., Iwashita N., Ohara-Imaizumi M., Ogihara T., Nagai S., Choi J.B., et al. Protein kinase Cdelta plays a non-redundant role in insulin secretion in pancreatic beta cells. J Biol Chem 2007, 282:2707-2716.
18. Greene M.W., Morrice N., Garofalo R.S., Roth R.A. Modulation of human insulin receptor substrate-1 tyrosine phosphorylation by protein kinase Cdelta. Biochem J 2004, 378:105-116.
19. Greene M.W., Ruhoff M.S., Burrington C.M., Garofalo R.S., Orena S.J. TNFalpha activation of PKCdelta, mediated by NFkappaB and ER stress, cross-talks with the insulin signaling cascade. Cell Signal 2010, 22:274-284.
20. Greene M.W., Ruhoff M.S., Roth R.A., Kim J.A., Quon M.J., Krause J.A. PKCdelta-mediated IRS-1 Ser24 phosphorylation negatively regulates IRS-1 function. Biochem Biophys Res Commun 2006, 349:976-986.
21. Chou W.H., Choi D.S., Zhang H., Mu D., McMahon T., Kharazia V.N., et al. Neutrophil protein kinase Cdelta as a mediator of stroke-reperfusion injury. J Clin Invest 2004, 114:49-56.
22. Seglen P.O. Preparation of isolated rat liver cells. Methods Cell Biol 1976, 13:29-83.
23. Berry M.N., Friend D.S. High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study. J Cell Biol 1969, 43:506-520.
24. Kreamer B.L., Staecker J.L., Sawada N., Sattler G.L., Hsia M.T., Pitot H.C. Use of a low-speed, iso-density percoll centrifugation method to increase the viability of isolated rat hepatocyte preparations. In Vitro Cell Dev Biol 1986, 22:201-211.
25. Newton A.C. Protein kinase C: poised to signal. Am J Physiol Endocrinol Metab 2010, 298:E395-E402.
26. Arii S., Imamura M. Physiological role of sinusoidal endothelial cells and Kupffer cells and their implication in the pathogenesis of liver injury. J Hepatobiliary Pancreat Surg 2000, 7:40-48.
27. Tacke F., Luedde T., Trautwein C. Inflammatory pathways in liver homeostasis and liver injury. Clin Rev Allergy Immunol 2009, 36:4-12.
28. Lanthier N., Molendi-Coste O., Horsmans Y., van Rooijen N., Cani P.D., Leclercq I.A. Kupffer cell activation is a causal factor for hepatic insulin resistance. Am J Physiol Gastrointest Liver Physiol 2010, 298:G107-G116.
29. Cai D., Yuan M., Frantz D.F., Melendez P.A., Hansen L., Lee J., et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 2005, 11:183-190.
30. Cheung A.T., Ree D., Kolls J.K., Fuselier J., Coy D.H., Bryer-Ash M. An in vivo model for elucidation of the mechanism of tumor necrosis factor-alpha (TNF-alpha)-induced insulin resistance: evidence for differential regulation of insulin signaling by TNF-alpha. Endocrinology 1998, 139:4928-4935.
31. Michael M.D., Kulkarni R.N., Postic C., Previs S.F., Shulman G.I., Magnuson M.A., et al. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 2000, 6:87-97.
32. Cheung A.T., Wang J., Ree D., Kolls J.K., Bryer-Ash M. Tumor necrosis factor-alpha induces hepatic insulin resistance in obese Zucker (fa/fa) rats via interaction of leukocyte antigen-related tyrosine phosphatase with focal adhesion kinase. Diabetes 2000, 49:810-819.
33. Han Y., Brasier A.R. Mechanism for biphasic rel A. NF-kappaB1 nuclear translocation in tumor necrosis factor alpha-stimulated hepatocytes. J Biol Chem 1997, 272:9825-9832.
34. Sun S.C., Ganchi P.A., Ballard D.W., Greene W.C. NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. Science 1993, 259:1912-1915.
35. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259:87-91.
36. Hotamisligil G.S., Spiegelman B.M. Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 1994, 43:1271-1278.
37. Raju J., Bird R.P. Alleviation of hepatic steatosis accompanied by modulation of plasma and liver TNF-alpha levels by Trigonella foenum graecum (fenugreek) seeds in Zucker obese (fa/fa) rats. Int J Obes (Lond) 2006, 30:1298-1307.
38. Aiston S., Peak M., Agius L. Impaired glycogen synthesis in hepatocytes from Zucker fatty fa/fa rats: the role of increased phosphorylase activity. Diabetologia 2000, 43:589-597.
39. Perkins N.D., Gilmore T.D. Good cop, bad cop: the different faces of NF-kappaB. Cell Death Differ 2006, 13:759-772.
40. Ron D., Chen C.H., Caldwell J., Jamieson L., Orr E., Mochly-Rosen D. Cloning of an intracellular receptor for protein kinase C: a homolog of the beta subunit of G proteins. Proc Natl Acad Sci U S A 1994, 91:839-843.
41. Csukai M., Chen C.H., De Matteis M.A., Mochly-Rosen D. The coatomer protein beta'-COP, a selective binding protein (RACK) for protein kinase Cepsilon. The Journal of biological chemistry 1997, 272:29200-29206.
42. Chen L., Hahn H., Wu G., Chen C.H., Liron T., Schechtman D., et al. Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC. Proc Natl Acad Sci U S A 2001, 98:11114-11119.
43. Braun M.U., Mochly-Rosen D. Opposing effects of delta- and zeta-protein kinase C isozymes on cardiac fibroblast proliferation: use of isozyme-selective inhibitors. J Mol Cell Cardiol 2003, 35:895-903.
44. Bright R., Raval A.P., Dembner J.M., Perez-Pinzon M.A., Steinberg G.K., Yenari M.A., et al. Protein kinase C delta mediates cerebral reperfusion injury in vivo. J Neurosci 2004, 24:6880-6888.
45. Tanaka M., Terry R.D., Mokhtari G.K., Inagaki K., Koyanagi T., Kofidis T., et al. Suppression of graft coronary artery disease by a brief treatment with a selective epsilonPKC activator and a deltaPKC inhibitor in murine cardiac allografts. Circulation 2004, 110:II194-II199.
46. Inagaki K., Chen L., Ikeno F., Lee F.H., Imahashi K., Bouley D.M., et al. Inhibition of delta-protein kinase C protects against reperfusion injury of the ischemic heart in vivo. Circulation 2003, 108:2304-2307.
47. Chen C.C., Wang J.K., Lin S.B. Antisense oligonucleotides targeting protein kinase C-alpha, -beta I, or -delta but not -eta inhibit lipopolysaccharide-induced nitric oxide synthase expression in RAW 264.7 macrophages: involvement of a nuclear factor kappa B-dependent mechanism. J Immunol 1998, 161:6206-6214.
48. Yang Y., Kaul S., Zhang D., Anantharam V., Kanthasamy A.G. Suppression of caspase-3-dependent proteolytic activation of protein kinase C delta by small interfering RNA prevents MPP+-induced dopaminergic degeneration. Mol Cell Neurosci 2004, 25:406-421.
49. Leitges M., Mayr M., Braun U., Mayr U., Li C., Pfister G., et al. Exacerbated vein graft arteriosclerosis in protein kinase Cdelta-null mice. J Clin Invest 2001, 108:1505-1512.
50. Mayr M., Metzler B., Chung Y.L., McGregor E., Mayr U., Troy H., et al. Ischemic preconditioning exaggerates cardiac damage in PKC-delta null mice. Am J Physiol Heart Circ Physiol 2004, 287:H946-H956.